Enhanced classification of Chagas serologic results and epidemiologic characteristics of seropositive donors at three large blood centers in Brazil

Transfusion

Volumn 50, Issue 12, 2010, Pages 2628-2637

  Sabino, Ester C ^a   Salles, Nanci A ^a   Sarr, Moussa ^a   Barreto, Angela M ^a   Oikawa, Marcio ^a   Oliveira, Cláudia D ^a   Leao, Silvana C ^a   Carneiro Proietti, Anna B ^a   Custer, Brian ^a   Busch, Michael P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; BLOOD ANALYSIS; BLOOD BANK; BRAZIL; CHAGAS DISEASE; CLASSIFICATION ALGORITHM; DEMOGRAPHY; DISEASE CLASSIFICATION; EDUCATION; ENZYME IMMUNOASSAY; FALSE POSITIVE RESULT; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; SEROLOGY; SEROPREVALENCE; SEX; TRYPANOSOMA CRUZI;

ADULT; ALGORITHMS; BLOOD BANKS; BLOOD DONORS; BRAZIL; CHAGAS DISEASE; DONOR SELECTION; FEMALE; HUMANS; MALE; SEROEPIDEMIOLOGIC STUDIES; SEROLOGIC TESTS; TRYPANOSOMA CRUZI; YOUNG ADULT;

EID: 78649987992     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02756.x     Document Type: Article

References (25)

1. Tarleton RL, Reithinger R, Urbina JA, Kitron U, Gürtler RE,. The challenges of Chagas Disease-grim outlook or glimmer of hope. PLoS Med 2007; 4: e332.
2. Wendel S,. Transfusion transmitted Chagas disease: is it really under control? Acta Trop 2010; 115: 28-34.
3. Gomes YM, Lorena VM, Luquetti AO,. Diagnosis of Chagas disease: what has been achieved? What remains to be done with regard to diagnosis and follow up studies? Mem Inst Oswaldo Cruz 2009; 104 Suppl 1: 115-21.
4. Otani MM, Vinelli E, Kirchhoff LV, Del Pozo A, Sands A, Vercauteren G, Sabino EC,. WHO comparative evaluation of serologic assays for Chagas disease. Transfusion 2009; 49: 1076-82.
5. Leiby DA, Herron RM Jr, Garratty G, Herwaldt BL,. Trypanosoma cruzi parasitemia in US blood donors with serologic evidence of infection. J Infect Dis 2008; 198: 609-13.
6. Britto CC,. Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations. Mem Inst Oswaldo Cruz 2009; 104 Suppl 1: 122-35.
7. Ramírez JD, Guhl F, Umezawa ES, Morillo CA, Rosas F, Marin-Neto JA, Restrepo S,. Evaluation of adult chronic Chagas' heart disease diagnosis by molecular and serological methods. J Clin Microbiol 2009; 47: 3945-51.
8. Umezawa ES, Luquetti AO, Levitus G, Ponce C, Ponce E, Henriquez D, Revollo S, Espinoza B, Sousa O, Khan B, Da Silveira JF,. Serodiagnosis of chronic and acute Chagas' disease with Trypanosoma cruzi recombinant proteins: results of a collaborative study in six Latin American countries. J Clin Microbiol 2004; 42: 449-52.
9. Chang CD, Cheng KY, Jiang LX, Salbilla VA, Haller AS, Yem AW, Bryant JD, Kirchhoff LV, Leiby DA, Schochetman G, Shah DO,. Evaluation of a prototype Trypanosoma cruzi antibody assay with recombinant antigens on a fully automated chemiluminescence analyzer for blood donor screening. Transfusion 2006; 46: 1737-44.
10. Umezawa ES, Bastos SF, Camargo ME, Yamauchi LM, Santos MR, Gonzalez A, Zingales B, Levin MJ, Sousa O, Rangel-Aldao R, Da Silveira JF,. Evaluation of recombinant antigens for serodiagnosis of Chagas' disease in South and Central America. J Clin Microbiol 1999; 37: 1554-60.
11. Caballero ZC, Sousa OE, Marques WP, Saez-Alquezar A, Umezawa ES,. Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp. Clin Vaccine Immunol 2007; 14: 1045-9.
12. Carvalho MR, Krieger MA, Almeida E, Oelemann W, Shikanai-Yassuda MA, Ferreira AW, Pereira JB, Sáez-Alquézar A, Dorlhiac-Llacer PE, Chamone DF,. Chagas' disease diagnosis: evaluation of several tests in blood bank screening. Transfusion 1993; 33: 830-4.
13. Coura JR, Fernandes O, Arboleda M, Barrett TV, Carrara N, Degrave W, Campbell DA,. Human infection by Trypanosoma rangeli in the Brazilian Amazon. Trans R Soc Trop Med Hyg 1996; 90: 278-9.
14. Remesar MC, Gamba C, Colaianni IF, Puppo M, Sartor PA, Murphy EL, Neilands TB, Ridolfi MA, Leguizamõn MS, Kuperman S, Del Pozo AE,. Estimation of sensitivity and specificity of several Trypanosoma cruzi antibody assays in blood donors in Argentina. Transfusion 2009; 49: 2352-8.
15. Salles NA, Sabino EC, Cliquet MG, Eluf-Neto J, Mayer A, Almeida-Neto C, Mendonça MC, Dorliach-Llacer P, Chamone DF, Saéz-Alquézar A,. Risk of exposure to Chagas' disease among seroreactive Brazilian blood donors. Transfusion 1996; 36: 969-73.
16. Carneiro-Proietti AB, Sabino EC, Sampaio D, Proietti FA, Gonçalez TT, Oliveira CD, Ferreira JE, Liu J, Custer B, Schreiber GB, Murphy EL, Busch MP,. Demographic profile of blood donors at three major Brazilian blood centers: results from the International REDS-II study, 2007 to 2008. Transfusion 2010; 50: 918-25.
17. SAS Institute I. SAS/STAT. Cary (NC): SAS Institute I; 2004.
18. Leiby DA, Wendel S, Takaoka DT, Fachini RM, Oliveira LC, Tibbals MA,. Serologic testing for Trypanosoma cruzi: comparison of radioimmunoprecipitation assay with commercially available indirect immunofluorescence assay, indirect hemagglutination assay, and enzyme-linked immunosorbent assay kits. J Clin Microbiol 2000; 38: 639-42.
19. Levy MZ, Bowman NM, Kawai V, Plotkin JB, Waller LA, Cabrera L, Steurer F, Seitz AE, Pinedo-Cancino VV, Cornejo del Carpio JG, Cordova Benzaquen E, McKenzie FE, Maguire JH, Gilman RH, Bern C,. Spatial patterns in discordant diagnostic test results for Chagas disease: links to transmission hotspots. Clin Infect Dis 2009; 48: 1104-6.
20. Remessar MC, Sabino EC, Gamba C, Busch MP, Tobler LH, Puppo M, Ridolfi MA, Kupperman S, Del Pozo AE,. Significance of inconclusive results on T. cruzi antibody assays in blood donors from a highly endemic region of Argentina. Transfusion 2009; 49 Suppl: 231a-2a.
21. Coura JR, Dias JC,. Epidemiology, control and surveillance of Chagas disease: 100 years after its discovery. Mem Inst Oswaldo Cruz 2009; 104 Suppl 1: 31-40.
22. De Andrade AL, Zicker F, De Oliveira RM, Almeida Silva S, Luquetti A, Travassos LR, Almeida IC, De Andrade SS, De Andrade JG, Martelli CM,. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet 1996; 348: 1407-13.
23. Viotti R, Vigliano C, Lococo B, Bertocchi G, Petti M, Alvarez MG, Postan M, Armenti A,. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial. Ann Intern Med 2006; 144: 724-34.
24. Souza FF, Castro-E-Silva O, Marin Neto JA, Sankarankutty AK, Teixeira AC, Martinelli AL, Gaspar GG, Melo L, Figueiredo JF, Romano MM, Maciel BC, Passos AD, Rossi MA,. Acute chagasic myocardiopathy after orthotopic liver transplantation with donor and recipient serologically negative for Trypanosoma cruzi: a case report. Transplant Proc 2008; 40: 875-8.
25. Cooley G, Etheridge RD, Boehlke C, Bundy B, Weatherly DB, Minning T, Haney M, Postan M, Laucella S, Tarleton RL,. High throughput selection of effective serodiagnostics for Trypanosoma cruzi infection. PLoS Negl Trop Dis 2008; 2: e316.